Cargando…
Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis
Background: Patients hospitalized with hematologic malignancy are particularly vulnerable to infection. We sought to determine the risk of Clostridium difficile infection (CDI) in hospitalization with multiple myeloma (MM), as well as its outcomes and trends, using a nationally representative databa...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561517/ https://www.ncbi.nlm.nih.gov/pubmed/31205828 http://dx.doi.org/10.7759/cureus.4391 |
_version_ | 1783426140737634304 |
---|---|
author | Ran-Castillo, Dan Oluwole, Adegbala Abuaisha, Munder Banks Paulino, Angela R Alkhatatneh, Ahmad Jang, Jeehoon Donaldson, Sahai Shammash, Jonathan Williams, Karlene |
author_facet | Ran-Castillo, Dan Oluwole, Adegbala Abuaisha, Munder Banks Paulino, Angela R Alkhatatneh, Ahmad Jang, Jeehoon Donaldson, Sahai Shammash, Jonathan Williams, Karlene |
author_sort | Ran-Castillo, Dan |
collection | PubMed |
description | Background: Patients hospitalized with hematologic malignancy are particularly vulnerable to infection. We sought to determine the risk of Clostridium difficile infection (CDI) in hospitalization with multiple myeloma (MM), as well as its outcomes and trends, using a nationally representative database. Methods: The Nationwide Inpatient Sample (NIS) from January 2010 to September 2015 was used for this study. We identified all patients aged 18 years or older with a diagnosis of MM using the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes. We identified trends in the annual rates of CDI in MM using negative binomial regressions with robust error variance. We conducted multivariate logistic regression to determine the incidence and the associated risk factors of CDI in MM and compared the outcomes between those with and without CDI using the propensity score method inverse probability weighting to adjust for baseline covariates. Results: In our cohort study of 114,249 MM patients, 45.96% were females and 54.04% were males. CDI was present in 3.1% of the MM patients. The number of CDI cases increased over the study period with an average rate of 3.27% per year. The mortality rate decreased over the same period with an average rate of 10% decrease per year. Hematopoietic stem cell transplantation (HSCT), neutropenia, inflammatory disease, atrial fibrillation (AF), and chronic kidney disease (CKD) were significant associated risk factors of CDI in MM patients. After adjusting for covariates, patients with CDI had a prolonged hospital stay, inpatient mortality, and significantly increased odds of acute kidney injury (AKI) and AKI requiring hemodialysis, along with higher healthcare resources utilization with significantly higher hospital costs. Conclusion: MM patients with CDI have significantly increased odds of inpatient mortality, AKI, and AKI requiring hemodialysis. They also have increased healthcare resource utilization compared with those without CDI. Despite the increased rate of the CDI over the years, the mortality rate is going down. |
format | Online Article Text |
id | pubmed-6561517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-65615172019-06-14 Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis Ran-Castillo, Dan Oluwole, Adegbala Abuaisha, Munder Banks Paulino, Angela R Alkhatatneh, Ahmad Jang, Jeehoon Donaldson, Sahai Shammash, Jonathan Williams, Karlene Cureus Internal Medicine Background: Patients hospitalized with hematologic malignancy are particularly vulnerable to infection. We sought to determine the risk of Clostridium difficile infection (CDI) in hospitalization with multiple myeloma (MM), as well as its outcomes and trends, using a nationally representative database. Methods: The Nationwide Inpatient Sample (NIS) from January 2010 to September 2015 was used for this study. We identified all patients aged 18 years or older with a diagnosis of MM using the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes. We identified trends in the annual rates of CDI in MM using negative binomial regressions with robust error variance. We conducted multivariate logistic regression to determine the incidence and the associated risk factors of CDI in MM and compared the outcomes between those with and without CDI using the propensity score method inverse probability weighting to adjust for baseline covariates. Results: In our cohort study of 114,249 MM patients, 45.96% were females and 54.04% were males. CDI was present in 3.1% of the MM patients. The number of CDI cases increased over the study period with an average rate of 3.27% per year. The mortality rate decreased over the same period with an average rate of 10% decrease per year. Hematopoietic stem cell transplantation (HSCT), neutropenia, inflammatory disease, atrial fibrillation (AF), and chronic kidney disease (CKD) were significant associated risk factors of CDI in MM patients. After adjusting for covariates, patients with CDI had a prolonged hospital stay, inpatient mortality, and significantly increased odds of acute kidney injury (AKI) and AKI requiring hemodialysis, along with higher healthcare resources utilization with significantly higher hospital costs. Conclusion: MM patients with CDI have significantly increased odds of inpatient mortality, AKI, and AKI requiring hemodialysis. They also have increased healthcare resource utilization compared with those without CDI. Despite the increased rate of the CDI over the years, the mortality rate is going down. Cureus 2019-04-05 /pmc/articles/PMC6561517/ /pubmed/31205828 http://dx.doi.org/10.7759/cureus.4391 Text en Copyright © 2019, Ran-Castillo et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Ran-Castillo, Dan Oluwole, Adegbala Abuaisha, Munder Banks Paulino, Angela R Alkhatatneh, Ahmad Jang, Jeehoon Donaldson, Sahai Shammash, Jonathan Williams, Karlene Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis |
title | Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis |
title_full | Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis |
title_fullStr | Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis |
title_full_unstemmed | Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis |
title_short | Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis |
title_sort | risk, outcomes, and trends of clostridium difficile infection in multiple myeloma patients from a nationwide analysis |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561517/ https://www.ncbi.nlm.nih.gov/pubmed/31205828 http://dx.doi.org/10.7759/cureus.4391 |
work_keys_str_mv | AT rancastillodan riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT oluwoleadegbala riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT abuaishamunder riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT bankspaulinoangelar riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT alkhatatnehahmad riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT jangjeehoon riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT donaldsonsahai riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT shammashjonathan riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis AT williamskarlene riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis |